A fund headquartered in San Francisco is investing from its most recent fund, which closed in late 2015 at $50 M. The firm invests in pre-seed through Series A rounds in exchange for equity. Typical allocations fall between $0.1 M-$2 M. The three main areas of interest for the firm are enterprise software, smart hardware, and data-driven healthcare. They will look at deals globally, but tend to focus on companies headquartered in North America.
The sectors of interest for the firm span medical technology, healthcare IT, suppliers and engineering, R&D services, and diagnostics. The firm invests in software and hardware with proprietary algorithmic and design principles. For example, big data, virtual reality, robotics, and machine learning are of interest. Their portfolio includes companies involved in deep learning for medical imaging, genomics platforms, large scale custom DNA synthesis, and a digital health platform consisting of software and integrated wearable hardware.
The firm seeks to work with management teams that have prior entrepreneurial experience in the market they are targeting. They are a passive investor, and do not usually seek a board seat but may if their background lends expertise to the venture.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com
Next Phase Newsletter 
Leave a comment